Optimizing Treatments for Heart Failure During Hospitalization (OPTICARD)

Central Hospital, Nancy, France

Status: Not yet enrolling

Conditions: Decompensated Heart Failure

Treatments: Other: Hospitalized patient for decompensated heart failure

Study type: Observational

Funder types: Other

Identifiers

NCT05910437

2022PI115

Details and patient eligibility

About

Heart failure reaches 1.5 million people in France and is responsible for 200,000 hospitalizations per year.

Over the past ten years, new therapies have emerged (treatment of martial deficiency, Entresto, iSGLT2).

Hospitalization in a context of acute heart failure is a moment of choice in the history of the disease to introduce recommended treatments under closer supervision (clinical, biological) than in ambulatory, and allows a decrease in hospitalizations, morbidity and mortality.

The purpose of this study is to describe the introduction of heart failure drugs (including iSGLT2) in real-life settings in patients hospitalized for decompensated heart failure.

Enrollment: 200 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patient ≥ 18 years
• Hospitalized (≥24h) for decompensated heart failure in cardiology.

Exclusion criteria

• Patient opposition participation in research and use of data.